Tenaya Therapeutics is a biotechnology company focused on discovering, designing, developing and delivering curative therapies that address the underlying drivers of heart disease. Co. is improving a pipeline of disease-modifying therapies developed using Co.'s product platforms and primary internal capabilities to target defined sub-populations of patients with prevalent forms of heart disease. The TNYA average annual return since 2021 is shown above.
The Average Annual Return on the TNYA average annual return since 2021 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether TNYA average annual return since 2021 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the TNYA average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|